Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy

Glucagon-like peptide-1 receptor agonists (GLP-1RAs, incretin mimetics) and dipeptidyl peptidase-4 inhibitors (DPP-4is, incretin enhancers) are glucose-lowering therapies with proven cardiovascular safety, but their effect on microvascular disease is not fully understood. Both therapies increase GLP...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldney, Jonathan, Sargeant, Jack A., Davies, Melanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474214/
https://www.ncbi.nlm.nih.gov/pubmed/37597048
http://dx.doi.org/10.1007/s00125-023-05988-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474214/
https://www.ncbi.nlm.nih.gov/pubmed/37597048
http://dx.doi.org/10.1007/s00125-023-05988-3

Ejemplares similares